Sylvia Sura-Trueba

发表

Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases

Seamus J. Martin, P. Davidovich, Tazhir Mametnabiev, 2018, Cell Death & Disease.

Insights into the organization of dorsal spinal cord pathways from an evolutionarily conserved raldh2 intronic enhancer

Saulo H. P. de Oliveira, N. Rosenthal, M. Nóbrega, 2010, Development.

Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case.

M. Polak, D. Lacombe, S. Romana, 2009, Human molecular genetics.

Identification of small‐molecule elastase inhibitors as antagonists of IL‐36 cytokine activation

Seamus J. Martin, P. Davidovich, A. Garabadzhiu, 2018, FEBS open bio.

Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development.

Juan I. Young, K. Walz, Sylvia Sura-Trueba, 2010, Human molecular genetics.

Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis

M. Polak, P. Czernichow, J. Amiel, 2007, Human Genetics.

Linkage and mutational analysis of familial thyroid dysgenesis demonstrate genetic heterogeneity implicating novel genes

S. Heath, M. Polak, P. Czernichow, 2005, European Journal of Human Genetics.

Molecular Mechanisms of Thyroid Dysgenesis

M. Polak, G. Szinnai, Sylvia Sura-Trueba, 2004, Hormone Research in Paediatrics.

An inactivating mutation within the first extracellular loop of the thyrotropin receptor impedes normal posttranslational maturation of the extracellular domain.

M. Polak, N. de Roux, Sylvia Sura-Trueba, 2009, Endocrinology.

Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases

Seamus J. Martin, P. Davidovich, A. Garabadzhiu, 2018, Cell Death & Disease.